| Katherine Bruya Reed, MD | |
|
510 S Cowley St Ste 200, Spokane, WA 99202-1332 | |
| (509) 456-8444 | |
| (509) 455-9227 |
| Full Name | Katherine Bruya Reed |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 20 Years |
| Location | 510 S Cowley St Ste 200, Spokane, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396919569 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD 60071865 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prov Sacred Hrt Med Ctr & Childs Hosp. | Spokane, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Washington | 0345139929 | 687 |
| Dermatology Specialists Of Spokane | 2567540503 | 7 |
News Archive
BioDelivery Sciences International, Inc. announced that it has entered into a license and supply agreement with Kunwha Pharmaceutical Co., Ltd., for the exclusive rights to develop and commercialize BEMA Fentanyl (marketed as ONSOLIS in the U.S.) in the Republic of Korea. The agreement results in potential milestone payments to BDSI of up to $1,275,000, which includes an upfront payment of $300,000. In addition, BDSI will receive an ongoing royalty based on net sales.
Scientists at the Virginia Tech Carilion Research Institute have discovered how the predominant class of Alzheimer's pharmaceuticals might sharpen the brain's performance.
Men and women in the U.S. had lower odds of depression diagnoses and better mental health during the Great Recession of 2007-09 compared to pre-recession according to a University of Maryland study published in the journal PLOS ONE.
Statins are a hugely popular drug class used to manage blood cholesterol levels and reduce the risk of heart disease. Previous studies had raised questions about adverse behavioral changes with statins, such as irritability or violence, but findings with statins have been inconsistent. In the first randomized trial to look at statin effects on behavior, researchers at the University of California, San Diego School of Medicine report that aggressive behavior typically declined among men placed on statins (compared to placebo), but typically increased among women placed on statins.
AMRI announced today that it has been selected as the inaugural winner of the Pfizer Route Design Innovation Award, beating out 40 companies who were invited to share innovative ideas for process chemistry and large scale Active Pharmaceutical Ingredient production. Pfizer will present the company with the award at the AMRI 2010 Integrated Drug Discovery Symposium to be held in Albany NY, October 13-14. AMRI will also receive an honorarium for its win.
› Verified 4 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194099390 PECOS PAC ID: 0345139929 Enrollment ID: O20040311001453 |
News Archive
BioDelivery Sciences International, Inc. announced that it has entered into a license and supply agreement with Kunwha Pharmaceutical Co., Ltd., for the exclusive rights to develop and commercialize BEMA Fentanyl (marketed as ONSOLIS in the U.S.) in the Republic of Korea. The agreement results in potential milestone payments to BDSI of up to $1,275,000, which includes an upfront payment of $300,000. In addition, BDSI will receive an ongoing royalty based on net sales.
Scientists at the Virginia Tech Carilion Research Institute have discovered how the predominant class of Alzheimer's pharmaceuticals might sharpen the brain's performance.
Men and women in the U.S. had lower odds of depression diagnoses and better mental health during the Great Recession of 2007-09 compared to pre-recession according to a University of Maryland study published in the journal PLOS ONE.
Statins are a hugely popular drug class used to manage blood cholesterol levels and reduce the risk of heart disease. Previous studies had raised questions about adverse behavioral changes with statins, such as irritability or violence, but findings with statins have been inconsistent. In the first randomized trial to look at statin effects on behavior, researchers at the University of California, San Diego School of Medicine report that aggressive behavior typically declined among men placed on statins (compared to placebo), but typically increased among women placed on statins.
AMRI announced today that it has been selected as the inaugural winner of the Pfizer Route Design Innovation Award, beating out 40 companies who were invited to share innovative ideas for process chemistry and large scale Active Pharmaceutical Ingredient production. Pfizer will present the company with the award at the AMRI 2010 Integrated Drug Discovery Symposium to be held in Albany NY, October 13-14. AMRI will also receive an honorarium for its win.
› Verified 4 days ago
| Entity Name | Dermatology Specialists Of Spokane |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912179599 PECOS PAC ID: 2567540503 Enrollment ID: O20080416000472 |
News Archive
BioDelivery Sciences International, Inc. announced that it has entered into a license and supply agreement with Kunwha Pharmaceutical Co., Ltd., for the exclusive rights to develop and commercialize BEMA Fentanyl (marketed as ONSOLIS in the U.S.) in the Republic of Korea. The agreement results in potential milestone payments to BDSI of up to $1,275,000, which includes an upfront payment of $300,000. In addition, BDSI will receive an ongoing royalty based on net sales.
Scientists at the Virginia Tech Carilion Research Institute have discovered how the predominant class of Alzheimer's pharmaceuticals might sharpen the brain's performance.
Men and women in the U.S. had lower odds of depression diagnoses and better mental health during the Great Recession of 2007-09 compared to pre-recession according to a University of Maryland study published in the journal PLOS ONE.
Statins are a hugely popular drug class used to manage blood cholesterol levels and reduce the risk of heart disease. Previous studies had raised questions about adverse behavioral changes with statins, such as irritability or violence, but findings with statins have been inconsistent. In the first randomized trial to look at statin effects on behavior, researchers at the University of California, San Diego School of Medicine report that aggressive behavior typically declined among men placed on statins (compared to placebo), but typically increased among women placed on statins.
AMRI announced today that it has been selected as the inaugural winner of the Pfizer Route Design Innovation Award, beating out 40 companies who were invited to share innovative ideas for process chemistry and large scale Active Pharmaceutical Ingredient production. Pfizer will present the company with the award at the AMRI 2010 Integrated Drug Discovery Symposium to be held in Albany NY, October 13-14. AMRI will also receive an honorarium for its win.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Bruya Reed, MD 510 S Cowley St Ste 200, Spokane, WA 99202-1332 Ph: (509) 456-8444 | Katherine Bruya Reed, MD 510 S Cowley St Ste 200, Spokane, WA 99202-1332 Ph: (509) 456-8444 |
News Archive
BioDelivery Sciences International, Inc. announced that it has entered into a license and supply agreement with Kunwha Pharmaceutical Co., Ltd., for the exclusive rights to develop and commercialize BEMA Fentanyl (marketed as ONSOLIS in the U.S.) in the Republic of Korea. The agreement results in potential milestone payments to BDSI of up to $1,275,000, which includes an upfront payment of $300,000. In addition, BDSI will receive an ongoing royalty based on net sales.
Scientists at the Virginia Tech Carilion Research Institute have discovered how the predominant class of Alzheimer's pharmaceuticals might sharpen the brain's performance.
Men and women in the U.S. had lower odds of depression diagnoses and better mental health during the Great Recession of 2007-09 compared to pre-recession according to a University of Maryland study published in the journal PLOS ONE.
Statins are a hugely popular drug class used to manage blood cholesterol levels and reduce the risk of heart disease. Previous studies had raised questions about adverse behavioral changes with statins, such as irritability or violence, but findings with statins have been inconsistent. In the first randomized trial to look at statin effects on behavior, researchers at the University of California, San Diego School of Medicine report that aggressive behavior typically declined among men placed on statins (compared to placebo), but typically increased among women placed on statins.
AMRI announced today that it has been selected as the inaugural winner of the Pfizer Route Design Innovation Award, beating out 40 companies who were invited to share innovative ideas for process chemistry and large scale Active Pharmaceutical Ingredient production. Pfizer will present the company with the award at the AMRI 2010 Integrated Drug Discovery Symposium to be held in Albany NY, October 13-14. AMRI will also receive an honorarium for its win.
› Verified 4 days ago
William Philip Werschler, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 104 W 5th Ave, 330w, Spokane, WA 99204 Phone: 509-624-1184 Fax: 509-625-1449 | |
Daniel Bowen Baird, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 757 E Holland Ave, Spokane, WA 99218 Phone: 509-444-6367 Fax: 509-444-6371 | |
Dr. Michael E Ryan, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 5901 N Lidgerwood St, Ste 118, Spokane, WA 99208 Phone: 509-483-2828 Fax: 509-484-7882 | |
James Keith Parker, MD Dermatology Medicare: Medicare Enrolled Practice Location: 5905 N Mayfair St Ste 200, Spokane, WA 99208 Phone: 509-456-7414 Fax: 800-247-9519 | |
Myron Zhang, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 400 E 5th Ave Ste 4, Spokane, WA 99202 Phone: 509-342-3945 Fax: 509-755-6580 | |
Benjamin Hsu, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 757 E Holland Ave, Northwest Dermatology, Spokane, WA 99218 Phone: 509-444-6367 Fax: 509-444-6371 | |
Dr. Lark Greenwald Guss, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 510 S Cowley St Ste 200, Spokane, WA 99202 Phone: 509-456-8444 Fax: 509-455-9227 |